Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Castagna

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Aging Medicine (Milton (N.S.W))|March 19, 2021
Progress in the risk assessment of hydroxychloroquine in frail elderly peopleAlberto Castagna, Giovanni Ruotolo, Ciro Manzo
Reumatologia|December 16, 2024
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literatureCiro Manzo, Marco Isetta, Alberto Castagna
Clinical and Experimental Rheumatology|October 10, 2023
Why would immuno- and endocrino-senescence, age-related changes in the gut microbiota, and susceptibility to infection favour polymyalgia rheumatica over seronegative elderly-onset rheumatoid arthritis?Ciro Manzo, Arvind Nune, Alberto Castagna
Life (Basel, Switzerland)|June 28, 2023
Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center StudyCiro Manzo, Alberto Castagna, Marco Isetta
Geriatrics & Gerontology International|December 1, 2020
Comprensive Geriatric Assessment in hospitalized older patients with COVID-19Alberto Castagna, Ciro Manzo, Giovanni Ruotolo
Reumatologia|January 23, 2023
Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?Ciro Manzo, Alberto Castagna, Arvind Nune
Drug Safety - Case Reports|March 5, 2017
Psychomotor Agitation Following Treatment with HydroxychloroquineCiro Manzo, Pietro Gareri, Alberto Castagna
Journal of the American Geriatrics Society|August 10, 2020
Comment on: Coronavirus 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19Alberto Castagna, Ciro Manzo, Giovanni Ruotolo
Clinical and Experimental Rheumatology|November 19, 2021
Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et alMarcin Milchert, Alberto Castagna, Ciro Manzo, et al.
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Aging Medicine (Milton (N.S.W))|March 19, 2021
Progress in the risk assessment of hydroxychloroquine in frail elderly peopleAlberto Castagna, Giovanni Ruotolo, Ciro Manzo
Reumatologia|December 16, 2024
Infective agents and polymyalgia rheumatica: key discussion points emerging from a narrative review of published literatureCiro Manzo, Marco Isetta, Alberto Castagna
Clinical and Experimental Rheumatology|October 10, 2023
Why would immuno- and endocrino-senescence, age-related changes in the gut microbiota, and susceptibility to infection favour polymyalgia rheumatica over seronegative elderly-onset rheumatoid arthritis?Ciro Manzo, Arvind Nune, Alberto Castagna
Life (Basel, Switzerland)|June 28, 2023
Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center StudyCiro Manzo, Alberto Castagna, Marco Isetta
Geriatrics & Gerontology International|December 1, 2020
Comprensive Geriatric Assessment in hospitalized older patients with COVID-19Alberto Castagna, Ciro Manzo, Giovanni Ruotolo
Reumatologia|January 23, 2023
Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?Ciro Manzo, Alberto Castagna, Arvind Nune
Drug Safety - Case Reports|March 5, 2017
Psychomotor Agitation Following Treatment with HydroxychloroquineCiro Manzo, Pietro Gareri, Alberto Castagna
Journal of the American Geriatrics Society|August 10, 2020
Comment on: Coronavirus 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19Alberto Castagna, Ciro Manzo, Giovanni Ruotolo
Clinical and Experimental Rheumatology|November 19, 2021
Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et alMarcin Milchert, Alberto Castagna, Ciro Manzo, et al.
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Pageof 10